12/3/15 16:20 | 12/1/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -19 | 1.50 | 1 | -13 | -5 | 222 | D | -7 | 21 | 7 | -24 | -22 | -9 | -1 | -1 | 2 | -1 | -11 | -33 | -44 | -49 |
11/4/15 16:48 | 11/2/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -25 | 1.98 | 1 | -13 | -5 | 235 | D | -3 | 42 | 57 | 15 | -18 | -9 | 2 | -1 | -2 | -10 | -22 | -54 | -30 | -54 |
10/5/15 18:02 | 10/1/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -28 | 2.27 | 3 | -13 | -5 | 247 | D | -9 | 77 | 48 | 37 | 40 | 0 | -3 | 3 | -5 | -6 | -16 | -46 | -52 | -64 |
9/2/15 17:55 | 9/1/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -24 | 1.88 | 1 | -13 | -5 | 260 | D | -35 | 35 | 17 | 29 | 7 | 14 | 14 | 5 | 2 | 12 | 16 | -24 | -53 | -88 |
8/5/15 09:20 | 8/3/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -21 | 1.71 | 1 | -13 | -4 | 272 | D | -44 | 38 | 1 | 36 | 5 | -4 | -3 | 0 | 0 | -1 | 16 | 17 | -51 | -67 |
7/2/15 16:06 | 7/1/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -20 | 1.61 | 1 | -13 | -4 | 285 | D | -41 | 9 | -11 | 2 | 24 | 7 | 0 | -3 | 1 | -1 | 2 | 37 | -21 | -71 |
6/2/15 16:51 | 6/1/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -16 | 1.24 | 1 | -13 | -4 | 297 | D | -45 | -16 | 6 | -19 | -12 | 3 | 2 | 3 | 3 | -1 | 13 | 29 | 7 | -45 |
5/5/15 17:06 | 5/1/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -17 | 1.33 | 1 | -13 | -4 | 310 | D | -47 | -19 | -4 | -22 | -23 | -14 | -14 | -10 | -1 | 4 | 17 | 35 | 59 | 13 |
4/3/15 11:58 | 4/1/15 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S | -32 | 1.58 | 1 | -20 | -5 | 420 | D | -38 | -17 | 28 | -16 | -3 | -2 | -8 | -4 | -1 | -1 | -18 | 6 | 43 | -27 |
3/11/14 17:21 | 3/10/14 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Brent L | OH | O | EVP,CFO, | S.d | -81 | 1.96 | 2 | -42 | -9 | 412 | D | -28 | -38 | -30 | 15 | 18 | 5 | 7 | 10 | 1 | 1 | -16 | -13 | -35 | -22 |
11/2/11 17:01 | 11/1/11 | NEOP | Neoprobe Corp | DE | Health | MdEq | Surgical & Medical Instrument | Larson Brent L | OH | O | SVP,CFO, | S.d | -34 | 2.75 | 0 | -13 | -4 | 316 | D | | | | | | | | | | | | | | |